Repligen Corporation is a pioneer in bioprocessing technologies, playing a crucial role in the manufacturing of biological drugs globally. With a product lineup that includes Protein A ligands essential for drug purification, innovative chromatography columns like OPUS, and a range of filtration devices, Repligen supports the biopharmaceutical industry's need for high-quality drug production. Their offerings extend to ELISA test kits and process analytics products, catering to life sciences, diagnostics, and biopharmaceutical companies. Founded in 1981 and based in Waltham, Massachusetts, Repligen is committed to advancing biomanufacturing with its collaborative and innovative solutions.

RGEN Articles